<code id='C7572459E2'></code><style id='C7572459E2'></style>
    • <acronym id='C7572459E2'></acronym>
      <center id='C7572459E2'><center id='C7572459E2'><tfoot id='C7572459E2'></tfoot></center><abbr id='C7572459E2'><dir id='C7572459E2'><tfoot id='C7572459E2'></tfoot><noframes id='C7572459E2'>

    • <optgroup id='C7572459E2'><strike id='C7572459E2'><sup id='C7572459E2'></sup></strike><code id='C7572459E2'></code></optgroup>
        1. <b id='C7572459E2'><label id='C7572459E2'><select id='C7572459E2'><dt id='C7572459E2'><span id='C7572459E2'></span></dt></select></label></b><u id='C7572459E2'></u>
          <i id='C7572459E2'><strike id='C7572459E2'><tt id='C7572459E2'><pre id='C7572459E2'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:39
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Europe is fastest
          Europe is fastest

          4:11ThesunrisesbehindtheBTTower,ashotweathercontinues,inLondon,June10,2023.TobyMelville/Reuters,FILE

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          AI generated plenty of interest at JPM but not a lot of trust

          AdobeYoudidn’tneedmachinelearningtomakeonepredictionabouttheyear’sbiggestconferenceforhealthcareinve